InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.500
-0.020 (-0.79%)
At close: Aug 13, 2025, 4:00 PM
2.500
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:58 AM EDT
InspireMD Employees
As of December 31, 2024, InspireMD had 86 total employees, including 85 full-time and 1 part-time employees. The number of employees increased by 20 or 30.30% compared to the previous year.
Employees
86
Change (1Y)
20
Growth (1Y)
30.30%
Revenue / Employee
$82,163
Profits / Employee
-$481,174
Market Cap
104.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NSPR News
- 8 days ago - InspireMD, Inc. (NSPR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - InspireMD Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 14 days ago - InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors - GlobeNewsWire
- 14 days ago - InspireMD Announces Combined Financings of $58 Million - GlobeNewsWire
- 23 days ago - InspireMD to Announce Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke - GlobeNewsWire
- 7 weeks ago - InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke - GlobeNewsWire
- 2 months ago - InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke - GlobeNewsWire